1Department of Radiology, The First Medical Center, Chinese PLA General Hospital, Beijing, China
2MR Research Collaboration Team, Siemens Healthineers Ltd. Shanghai, Shanghai, China
Presenting Author: Chaobang Xie
Synopsis
Motivation:
Goals:
Approach:
Results:
Full abstract & presentation
The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.
Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.
To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.
1. Markus H S, Joutel A. The pathogenesis of cerebral small vessel disease and vascular cognitive impairment [J]. Physiol Rev, 2025, 105(3): 1075-1171. DOI:10.1152/physrev.00028.2024. [doi]
2. Dupré N, Drieu A, Joutel A. Pathophysiology of cerebral small vessel disease: a journey through recent discoveries [J]. Journal of Clinical Investigation, 2024, 134(10): e172841. DOI:10.1172/JCI172841. [doi]
3. Hilkens N A, Casolla B, Leung T W, et al. Stroke [J]. Lancet, 2024, 403(10446): 2820-2836. DOI:10.1016/S0140-6736(24)00642-1. [doi]
4. Li H, Cheng M, Gao Y, et al. Does the burden of CSVD modify the efficacy of dual antiplatelet therapy?: a post hoc analysis of the INSPIRES trial [J]. Stroke, 2025, 56(6): 1376-1387. DOI:10.1161/STROKEAHA.124.049826. [doi]
5. Li Y, Zhang D, Han F, et al. Clonal hematopoiesis of indeterminate potential associated with covert cerebral changes [J]. Ann Neurol, 2025: ana.27304. DOI:10.1002/ana.27304. [doi]
6. Lam B Y K, Cai Y, Akinyemi R, et al. The global burden of cerebral small vessel disease in low- and middle-income countries: A systematic review and meta-analysis [J]. International Journal of Stroke, 2022, 18(1): 15-27. DOI:10.1177/17474930221137019. [doi]
7. Van Den Brink H, Pham S, Siero J C, et al. Assessment of small vessel function using 7T MRI in patients with sporadic cerebral small vessel disease: the ZOOM@SVDs study [J]. Neurology, 2024, 102(5): e209136. DOI:10.1212/WNL.0000000000209136. [doi]
8. Sarabi M S, Ma S J, Jann K, et al. Vessel density mapping of small cerebral vessels on 3D high resolution black blood MRI [J]. Neuroimage, 2024, 286: 120504. DOI:10.1016/j.neuroimage.2023.120504. [doi]
9. Kopczak A, Stringer M S, Van Den Brink H, et al. Effect of blood pressure-lowering agents on microvascular function in people with small vessel diseases (TREAT-SVDs): a multicentre, open-label, randomised, crossover trial [J]. Lancet Neurology, 2023, 22(11): 991-1004. DOI:10.1016/s1474-4422(23)00293-4. [doi]
10. Webb A J, Feakins K, Lawson A, et al. White matter hyperintensities are independently associated with systemic vascular aging and cerebrovascular dysfunction [J]. International Journal of Stroke, 2025, 20(5): 581-589. DOI:10.1177/17474930241306987. [doi]
11. Kwon H-M, Lynn M J, Turan T N, et al. Frequency, risk factors, and outcome of coexistent small vessel disease and intracranial arterial stenosis: results from the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) trial [J]. JAMA Neurol, 2016, 73(1): 36. DOI:10.1001/jamaneurol.2015.3145. [doi]
12. Zheng L, Tian X, Abrigo J, et al. Hemodynamic significance of intracranial atherosclerotic disease and ipsilateral imaging markers of cerebral small vessel disease [J]. Eur Stroke J, 2024, 9(1): 144-153. DOI:10.1177/23969873231205669. [doi]
13. Wardlaw J M, Smith C, Dichgans M. Small vessel disease: mechanisms and clinical implications [J]. The Lancet Neurology, 2019, 18(7): 684-696. DOI:10.1016/s1474-4422(19)30079-1. [doi]
14. Li R, Lyu J, Hu R, et al. Morphological study on lenticulostriate arteries in patients with middle cerebral artery stenosis at 7 T MRI [J]. Journal of Magnetic Resonance Imaging, 2025: jmri.29693. DOI:10.1002/jmri.29693. [doi]
15. Zhang Z, Fan Z, Kong Q, et al. Visualization of the lenticulostriate arteries at 3T using black-blood T1-weighted intracranial vessel wall imaging: comparison with 7T TOF-MRA [J]. Eur Radiol, 2019, 29(3): 1452-1459. DOI:10.1007/s00330-018-5701-y. [doi]
16. Zhang Y, Chang P, Liu N, et al. Correlation between lenticulostriate arteries and white matter microstructure changes in patients with cerebral small vessel disease [J]. Front Neurosci, 2023, 17. DOI:10.3389/fnins.2023.1202538. [doi]
17. Van Den Brink H, Doubal F N, Duering M. Advanced MRI in cerebral small vessel disease [J]. International Journal of Stroke, 2023, 18(1): 28-35. DOI:10.1177/17474930221091879. [doi]
18. Jiaerken Y, Benjamin P, Rodgers C T, et al. In vivo visualisation of charcot-bouchard aneurysms on lenticulostriate arteries using 7T MRI [J]. American Journal of Neuroradiology, 2025: ajnr.A8705. DOI:10.3174/ajnr.A8705. [doi]
19. Samuels O B, Joseph G J, Lynn M J, et al. A standardized method for measuring intracranial arterial stenosis [J]. AJNR American Journal of Neuroradiology, 2000, 21(4): 643-646.
20. Jiang S, Cao T, Yan Y, et al. Lenticulostriate artery combined with neuroimaging markers of cerebral small vessel disease differentiate the pathogenesis of recent subcortical infarction [J]. J Cereb Blood Flow Metab, 2021, 41(8): 2105-2115. DOI:10.1177/0271678x21992622. [doi]
21. Duering M, Biessels G J, Brodtmann A, et al. Neuroimaging standards for research into small vessel disease—advances since 2013 [J]. The Lancet Neurology, 2023, 22(7): 602-618. DOI:10.1016/s1474-4422(23)00131-x. [doi]
22. Liu Y, Li S, Tian X, et al. More severe cerebral small vessel disease associated with poor leptomeningeal collaterals in symptomatic intracranial atherosclerotic stenosis [J]. J Cereb Blood Flow Metab, 2025, 45(4): 655-663. DOI:10.1177/0271678x241292537. [doi]